Telemedicine Management of Chronic Insomnia
VIP
Telemedicine Management of Veterans With PTSD and Chronic Insomnia
1 other identifier
interventional
114
1 country
1
Brief Summary
Insomnia is commonly present in Veterans with post-traumatic stress disorder (PTSD). Treatment of insomnia with a specialized type of psychotherapy has been shown to be more effective than treatment with medications. Unfortunately, few psychologists are trained to provide this treatment, limiting Veterans' access to care, especially those Veterans in remote and rural areas. This project will evaluate the ability to deliver this psychotherapy to groups of Veterans by video teleconferencing. Groups of Veterans with PTSD and chronic insomnia will receive the psychotherapy treatment either by meeting in-person with the psychologist or by the psychologist delivering the treatment by video teleconferencing. Finding that video teleconferencing is a cost effective way to deliver this treatment could add an important new component to the care of Veterans with PTSD that provides an alternative to medications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 6, 2012
CompletedFirst Posted
Study publicly available on registry
September 18, 2012
CompletedStudy Start
First participant enrolled
April 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2016
CompletedResults Posted
Study results publicly available
August 29, 2019
CompletedAugust 29, 2019
July 1, 2019
3.7 years
September 6, 2012
February 7, 2019
July 22, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change From Baseline in Insomnia Severity Index Score
Self-report questionnaire used widely to assess presence of insomnia and its severity. Scores range from 0-28. Higher scores indicate increasing severity of insomnia.
Baseline to 3 months
Secondary Outcomes (13)
Change From Baseline PTSD Checklist-Military (PCL-M) Scores
baseline to 3 months
Change From Baseline Pittsburgh Sleep Quality Index (PSQI) Scores
baseline to 3 months
Change From Baseline in Pittsburgh Sleep Quality Index Addendum for PTSD (PSQI-A)
baseline to 3 months
Change From Baseline in Nightmare Distress Questionnaire Scores
baseline to 3 month
Change From Baseline Medical Outcomes Study Short Form-12 (SF-12) Mental Component Score
baseline to 3 months
- +8 more secondary outcomes
Study Arms (2)
CBT-I delivery by video teleconferencing
EXPERIMENTALGroups of participants will receive a cognitive behavioral therapy for insomnia program delivered by a trained psychologist using video teleconferencing.
In-person CBT-I delivery
ACTIVE COMPARATORGroups of participants will receive a cognitive behavioral therapy for insomnia (CBT-I) program by meeting in-person with a trained psychologist.
Interventions
A behavioral modification program consisting of 6 clinic sessions focused on sleep hygiene, stimulus control, sleep restriction, and cognitive restructuring.
Eligibility Criteria
You may qualify if:
- Men and women at least 18 years of age.
- Meet current DSM-IV-TR criteria for PTSD as determined by the Clinician Administered PTSD Scale (CAPS)
- Insomnia Severity Index score \> 14, the commonly used threshold for clinical insomnia, with self-reported duration of insomnia \>6 months.
- Ability to read and speak English (assessment instruments and therapy will be available only in English)
You may not qualify if:
- Unable or unwilling to provide informed consent.
- Unwilling to participate in supervised group sessions at the community based outpatient clinic
- No telephone access or inability to return for follow-up testing.
- Individuals with an untreated sleep disorder \[e.g., obstructive sleep apnea (apnea-hypopnea index 15 events/hr), periodic limb movement disorder (10 leg movements/hr of sleep with arousals), central sleep apnea ( 50% of apneas are central), Cheyne-Stokes respiration, obesity hypoventilation syndrome, and narcolepsy\].
- A clinically unstable medical condition as defined by a new diagnosis or change in medical management in the previous 2 months.
- Evidence of substance dependence during the preceding twelve months. Evidence of "at risk" drinking behavior over the past month. Namely for men: more than 4 drinks on a given night, drinking on more than 3 nights a week, or more than 14 total drinks in a week; for women: more than 3 drinks in a given night, drinking on more than 3 nights a week, or more than 7 total drinks in a week.
- Individuals with bipolar disorder, delirium, dementia, amnestic disorder, schizophrenia and other psychotic disorders as determined by the SCID questionnaire. A concurrent anxiety disorder or depressive disorder diagnosis will be allowed.
- Individuals with prominent current suicidal or homicidal ideation. This will be assessed by the clinical psychologist administering the SCID and CAPS. In cases of prominent current suicidal or homicidal ideation appropriate safety measures will be taken. Following stabilization, Veterans who continue to be interested in participating in the study may be re-assessed.
- Unable to perform tests due to inability to communicate verbally, inability to read and write; less than a 5th grade reading level; visual, hearing or cognitive impairment (e.g., previous head injury).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- VA Office of Research and Developmentlead
- University of Pennsylvaniacollaborator
Study Sites (1)
Philadelphia VA Medical Center, Philadelphia, PA
Philadelphia, Pennsylvania, 19104, United States
Related Publications (1)
Gehrman P, Shah MT, Miles A, Kuna S, Godleski L. Feasibility of Group Cognitive-Behavioral Treatment of Insomnia Delivered by Clinical Video Telehealth. Telemed J E Health. 2016 Dec;22(12):1041-1046. doi: 10.1089/tmj.2016.0032. Epub 2016 Jun 10.
PMID: 27286369RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Samuel T. Kuna
- Organization
- Crescenz VA Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Samuel T. Kuna, MD
Philadelphia VA Medical Center, Philadelphia, PA
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 6, 2012
First Posted
September 18, 2012
Study Start
April 1, 2013
Primary Completion
November 30, 2016
Study Completion
November 30, 2016
Last Updated
August 29, 2019
Results First Posted
August 29, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will not share